Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion type Assertion NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_head.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_provenance.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion evidence source_evidence_literature NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_provenance.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion SIO_000772 17957790 NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_provenance.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion wasDerivedFrom befree-20140225 NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_provenance.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion wasGeneratedBy ECO_0000203 NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_provenance.